Navigation Links
New antibiotic could make food safer and cows healthier
Date:3/19/2012

CHAMPAIGN, Ill. Food-borne diseases might soon have another warrior to contend with, thanks to a new molecule discovered by chemists at the University of Illinois. The new antibiotic, an analog of the widely used food preservative nisin, also has potential to be a boon to the dairy industry as a treatment for bovine mastitis.

The antibiotic nisin occurs naturally in milk, a product of bacteria resident in the cow's udder. It helps keep milk from spoiling and kills a broad spectrum of bacteria that cause food-borne illness, most notably listeria and clostridium. It was approved as a food additive in 1969, and since then has become prevalent in the food industry in more than 50 countries.

"It's good to know that there are natural products added to our food that protect us from diseases," said lead researcher Wilfred van der Donk, a chemistry professor at Illinois. "Many people probably don't even realize that, or think it's some kind of a non-natural chemical. Last summer we had the listeria outbreak, and that's a good example of people dying from pathogens in food. You don't hear of such outbreaks often, and that's in part because of the compounds that are added to food to kill the pathogens."

Nisin also shows promise as a treatment for bovine mastitis, an infection in cows that costs the dairy industry billions each year since milk produced during and shortly after antibiotic treatment has to be thrown out. Since nisin already is present in low levels in milk, farmers using nisin to treat mastitis may not need to discard milk or meat from recently treated animals.

However, for all its utility, nisin has drawbacks. It's produced in an acidic environment, but it becomes unstable at the neutral pH levels needed for many foods or pharmaceuticals. It also becomes unstable at higher temperatures, limiting its uses.

While studying the genome of another bacterium that lives at high temperatures, van der Donk's group found genes to make a molecule with a similar structure and function to nisin, known as an analog. They isolated the genes and inserted them into E. coli so they could produce the new antibiotic, dubbed geobacillin, in large enough quantities to study its structure and function.

"As it turns out, geobacillin is more stable, both in respect to pH and temperature," van der Donk said. "We think this is good news for potential use of geobacillin in food."

Nisin, and presumably geobacillin, work by binding to a molecule the pathogen needs to build its cell wall and then poking holes in the bacterial cell's membrane, a one-two punch that quickly kills the invader. However, the two antibiotics have slight structural differences. Nisin's structure has five looped regions, formed by cross-links in the protein chain. Geobacillin has seven loops thanks to two additional cross-links, which give the protein added stability.

The team tested geobacillin against several foodborne and disease-causing bacteria and found it similarly effective or more effective than nisin, depending on the bacteria. Most significantly, it was three times more active against the main contagious bacteria responsible for bovine mastitis. Contagious mastitis is devastating for dairy farmers, as the bacteria can quickly spread throughout a herd. In addition, since mastitis could be caused by a number of different infections, geobacillin's broad-spectrum activity makes it a very attractive treatment option.

Next, the researchers plan to test geobacillin against a wider spectrum of disease-causing bacteria. Many tests of safety, efficacy and economic production lie ahead, although geobacillin has shown great promise in tests to date. The researchers hope that its greater stability will enable medicinal applications for geobacillin that nisin could not realize, both for bovine mastitis and possibly for human disease.

"Nisin was very promising in early preclinical trials in that it was very effective in killing multidrug-resistant bacteria in mouse models," said van der Donk, "but because of its instability, it has a very short half-life in blood. So we're looking to see whether geobacillin has greater serum stability."

The researchers published their findings in the Proceedings of the National Academy of Sciences. The National Institutes of Health supported this work. Van der Donk is also a Howard Hughes Medical Investigator.


'/>"/>

Contact: Liz Ahlberg
eahlberg@illinois.edu
217-244-1073
University of Illinois at Urbana-Champaign
Source:Eurekalert  

Related biology news :

1. Team discovers how bacteria resist a Trojan horse antibiotic
2. Exposure to antibiotics linked to severity of allergic asthma: UBC research
3. Researchers attempt to solve problems of antibiotic resistance and bee deaths in one
4. Patterns of antibiotic-resistant bacteria found in Galapagos reptiles
5. Polar growth at the bacterial scale reveals potential new targets for antibiotic therapy
6. Drugs used to overcome cancer may also combat antibiotic resistance: McMaster researchers
7. Targeted antibacterial proteins may offer antibiotic alternative
8. Targeting bacterial gas defenses allow for increased efficacy of numerous antibiotics
9. Alarming pattern of antibiotic use in the southeastern United States
10. Evidence supports ban on growth promotion use of antibiotics in farming
11. Texas A&M center confronts antibiotic crisis with potential new bacterial treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New antibiotic could make food safer and cows healthier
(Date:6/11/2020)... ... June 09, 2020 , ... Superior Controls, Inc. , ... and IT solutions for the life sciences industry, is pleased to announce the recent ... out of the company’s Seabrook, New Hampshire office. In his new role, Boudreau ...
(Date:6/5/2020)... ... 04, 2020 , ... Greffex, a pioneering vaccine and gene therapy company based ... understands the need for a global perspective to make an impact in a post ... will serve as an independent, director of the company. , “The Greffex board is ...
(Date:5/28/2020)... ... ... CrucialTrak, a global designer and manufacturer of biometric access control systems, today announced ... sell its complete line of biometric readers and access gates . CEG is ... , Brett Mason, CrucialTrak’s Director of Channel Sales for the Americas is very ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 30, 2020 , ... ... today announced the release of its signature product called Beacon - a ... and other field medical professionals. , Beacon helps MSLs streamline communication ...
(Date:7/18/2020)... ... 2020 , ... Medial EarlySign , a leader in ... high-burden diseases, and Centric Consulting, a business and technology consulting firm, today announced ... in order to identify and prioritize patients for care. , Combining Centric’s management ...
(Date:7/10/2020)... ... July 09, 2020 , ... In most research ... to suppress pigment formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic ... MA has been using the zebrafish model to investigate the causes of leukaemia ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... of 40% in 2020, despite many obstacles created as a result of COVID-19. ... revenue for its partnered medical practices and medical manufacturers by expanding access to ...
Breaking Biology Technology: